Arecor Therapeutics PLC (AIM:AREC) said it has secured pivotal patent protection for two fast-acting insulin assets, AT278 and AT247. The European Patent.
Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Arecor is awarded key patents in the EU and China protecting the novel formulations of its proprietary Arestat insulin products, AT278 and AT247. The European Patent .
TRADING UPDATES: Narf Industries audit delay; Arecor wins patent lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Arecor Therapeutics PLC (AIM:AREC), the UK biopharmaceutical group, has been granted patents in India and the US, protecting its proprietary formulations of.